Danaher Corp (DHR)

Industry Diagnostics & Research
This stock can be held in an Investment ISA and an Investment Account
Sell

$230.00

Buy

$235.89

arrow-down$-4.75 (-2.00%)

Prices updated at 30 Oct 2026, 23:47 EDT
| Prices minimum 15 mins delay
|
Prices in USD
In 1984, Danaher’s founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instrumen ...
S&P 500
arrow-down-1.82%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
our Investment Fees and Charges.
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Mr. Steven M. Rales
CEO
Ms. Julie A. Sawyer Montgomery
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
60,000
Head office
2200 Pennsylvania Avenue, NW
Washington
United States
20037-1701
mobile
+1 202 828-0850
letter
investor.relations@danaher.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Ms. Julie A. Sawyer Montgomery
Director, President and Chief Executive Officer
0.85m
Mr. Alan G. Spoon, J.D.
Independent Director
-
Ms. Linda Hefner Filler
Lead Independent Director
0.19m
Mr. Mitchell P. Rales
Director
-
Mr. Steven M. Rales
Chairman of the Board
-
Dr. Elias A. Zerhouni, M.D.
Independent Director
-
Ms. Teri L. List-Stoll
Independent Director
0.16m
Mr. R. Bradley Gray
Senior Vice President, Strategic Development
-
Mr. Matthew R. McGrew
Executive Vice President
1.01m
Mr. Jonathan B. Leiken
Senior Vice President and Chief Legal Officer
-
Mr. Matthew E. Gugino
Executive Vice President and Chief Financial Officer
-
Dr. Jose-Carlos Gutierrez-Ramos, PhD
Senior Vice President and Chief Science Officer
0.89m
Mr. Feroz Dewan
Independent Director
-
Professor Raymond C. Stevens, PhD
Independent Director
-
Mr. A. Shane Sanders
Independent Director
-
Mr. Christopher M. Bouda
Vice President and Chief Accounting Officer
-
Mr. Christopher Paul Riley
Executive Vice President
0.85m
Mr. Charles W. Lamanna
Independent Director
0.11m
Mr. Gregory M. Milosevich
Executive Vice President
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
BlackRock Inc51,640,619
Vanguard Capital Management, LLC41,127,810
Vanguard Group Inc37,619,523
State Street Corp27,894,181
Capital Research and Management Company25,686,591

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
30 Dec 2025-
25 Nov 2025-
25 Nov 2025-
25 Nov 2025-
18 Nov 2025-
18 Nov 2025-
18 Nov 2025-
15 Nov 2025-
15 Nov 2025-
15 Nov 2025-
12 Nov 2025-
12 Nov 2025-
12 Nov 2025-
12 Nov 2025-
12 Nov 2025-
12 Nov 2025-
12 Nov 2025-
12 Nov 2025-
12 Nov 2025-
12 Nov 2025-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.